Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD
Autor: | Cahn, A., Hamblin, J.N., Begg, M., Wilson, R., Dunsire, L., Sriskantharajah, S., Montembault, M., Leemereise, C.N., Galinanes-Garcia, L., Watz, H., Kirsten, A.M., Fuhr, R., Hessel, E.M. |
---|---|
Zdroj: | In Pulmonary Pharmacology & Therapeutics October 2017 46:69-77 |
Databáze: | ScienceDirect |
Externí odkaz: |